Image 1 of 1
Design History File (DHF) Review & Remediation Advisory - Free (No Form of Payment Required)
Designed for medical device manufacturers and development teams who need an expert eye on their Design History File, whether you are preparing for an FDA inspection, responding to a 510(k) deficiency, or simply unsure whether your DHF would hold up under scrutiny.
This complimentary consultation is a structured 45-minute conversation with an experienced medical device regulatory consultant. No sales pitch. Just a focused, candid assessment of where your DHF stands and what it will take to get it inspection-ready.
What We Cover
Depending on your situation and priorities, the conversation will focus on the areas most relevant to your current stage. This may include:
• DHF structure and overall completeness
• Design input and design output documentation
• Design review records and approval trails
• Verification and validation coverage
• Traceability between requirements and test evidence
• Design transfer documentation
• Alignment with FDA design control requirements under 21 CFR Part 820 and ISO 13485
What You Walk Away With
A clear picture of your most significant DHF gaps, a prioritized remediation roadmap, and a straightforward recommendation on whether a productized documentation system, a targeted consulting engagement, or a combination of both is the right next step for your organization.
Who This Is For
This consultation is built for device manufacturers at any stage, whether you are building your DHF for the first time, remediating gaps identified in an FDA warning letter or inspection observation, closing deficiencies flagged in a 510(k) review, or simply stress-testing your existing DHF before your next audit. If your DHF keeps you up at night, this call is for you.
How It Works
We will contact you for a time that works for you. You will receive a brief preparation guide to help focus the conversation on your specific device, development stage, and regulatory context. No formal preparation required beyond that.
What This Is Not
This consultation is not a substitute for a full DHF audit, regulatory strategy engagement, submission support, or ongoing quality management consulting. If your needs extend beyond an advisory conversation, [link to your consulting services page] may be a better fit.
Typical Outcomes From This Call
Every situation is different, but most teams leave this call with one of the following outcomes:
Outcome 1: Minor Structural Improvements
Your Design History File structure is generally sound. We identify several targeted improvements to strengthen traceability, documentation completeness, or design review evidence so your DHF better aligns with FDA design control expectations.
Outcome 2: Targeted Gap Remediation
A handful of meaningful gaps are identified — often involving design inputs/outputs, verification and validation coverage, traceability, or design review documentation. We outline a prioritized remediation approach to address the highest-risk areas efficiently.
Outcome 3: Foundational DHF Structure Needs Work
Your current DHF structure may be incomplete, fragmented, or not clearly aligned with FDA design control requirements under 21 CFR Part 820. In these cases we typically recommend either a structured documentation framework or a focused remediation engagement to stabilize the system quickly.
Designed for medical device manufacturers and development teams who need an expert eye on their Design History File, whether you are preparing for an FDA inspection, responding to a 510(k) deficiency, or simply unsure whether your DHF would hold up under scrutiny.
This complimentary consultation is a structured 45-minute conversation with an experienced medical device regulatory consultant. No sales pitch. Just a focused, candid assessment of where your DHF stands and what it will take to get it inspection-ready.
What We Cover
Depending on your situation and priorities, the conversation will focus on the areas most relevant to your current stage. This may include:
• DHF structure and overall completeness
• Design input and design output documentation
• Design review records and approval trails
• Verification and validation coverage
• Traceability between requirements and test evidence
• Design transfer documentation
• Alignment with FDA design control requirements under 21 CFR Part 820 and ISO 13485
What You Walk Away With
A clear picture of your most significant DHF gaps, a prioritized remediation roadmap, and a straightforward recommendation on whether a productized documentation system, a targeted consulting engagement, or a combination of both is the right next step for your organization.
Who This Is For
This consultation is built for device manufacturers at any stage, whether you are building your DHF for the first time, remediating gaps identified in an FDA warning letter or inspection observation, closing deficiencies flagged in a 510(k) review, or simply stress-testing your existing DHF before your next audit. If your DHF keeps you up at night, this call is for you.
How It Works
We will contact you for a time that works for you. You will receive a brief preparation guide to help focus the conversation on your specific device, development stage, and regulatory context. No formal preparation required beyond that.
What This Is Not
This consultation is not a substitute for a full DHF audit, regulatory strategy engagement, submission support, or ongoing quality management consulting. If your needs extend beyond an advisory conversation, [link to your consulting services page] may be a better fit.
Typical Outcomes From This Call
Every situation is different, but most teams leave this call with one of the following outcomes:
Outcome 1: Minor Structural Improvements
Your Design History File structure is generally sound. We identify several targeted improvements to strengthen traceability, documentation completeness, or design review evidence so your DHF better aligns with FDA design control expectations.
Outcome 2: Targeted Gap Remediation
A handful of meaningful gaps are identified — often involving design inputs/outputs, verification and validation coverage, traceability, or design review documentation. We outline a prioritized remediation approach to address the highest-risk areas efficiently.
Outcome 3: Foundational DHF Structure Needs Work
Your current DHF structure may be incomplete, fragmented, or not clearly aligned with FDA design control requirements under 21 CFR Part 820. In these cases we typically recommend either a structured documentation framework or a focused remediation engagement to stabilize the system quickly.